The general pharmaceutical principles for handling lyophilised peptides apply to CJC-1295. However, no independently published, peer-reviewed stability study specific to this compound was identified in the scientific literature reviewed for this series. This means that the specific durability numbers commonly seen online – such as „use within 7–14 days” or „stable for 28 days” – originate from manufacturer or vendor guidelines, rather than published, independently verified studies. This distinction is treated with due diligence throughout this article.
How to store CJC-1295
CJC-1295, like most peptides, is supplied as a lyophilised powder. This is because this dry, powdered state is generally more chemically stable than a peptide already dissolved in liquid. In fact, this dry powder form has the longest documented storage stability of all the forms the compound takes. The general best practice for lyophilised peptides, consistent throughout the pharmaceutical and laboratory industries, is quite straightforward. Store the unopened powder in a cool, dry, dark location, protected from light and moisture. Supplier sources and laboratory handling commonly recommend storage in a freezer – around -20°C or colder – for the longest possible shelf life of unmixed powder.
Once the powder has been mixed with liquid (a process called reconstitution), a different rule applies. The general pharmaceutical convention – the same rule applied to many injectable peptide and protein products, such as insulin – states that the resulting solution should be refrigerated, commonly cited as between 2–8°C, and not left at room temperature. This is because dissolved peptides are generally more susceptible to degradation from heat, light, and time than their lyophilised counterparts.
It is worth being direct here. These storage practices reflect general, well-established principles for handling peptides as a category, consistently reiterated in commercial and laboratory supplier guidelines. They are not findings from a dedicated, independently published stability study specifically measuring how CJC-1295 breaks down under controlled conditions.
How long does CJC-1295 last in the fridge?
This is an area where the greatest caution is advised. Commercial and laboratory sources commonly cite reconstituted CJC-1295 as remaining stable under refrigeration for one to four weeks, although different sources offer different specific numbers within this general range. These numbers should be understood as manufacturer or vendor guidelines and general industry convention – not as findings from an independently conducted, peer-reviewed stability study. No such published study measuring the actual rate of CJC-1295 degradation over time after reconstitution has been identified in the scientific literature reviewed for this report.
This is an important distinction to understand. A manufacturer stating a longevity number on their own product page is not the same as a controlled laboratory study measuring how much intact peptide actually remains at set time points after mixing. The latter, a more rigorous type of independent verification, does not appear to yet exist in the published record for this particular compound.
Given this gap, this article will not present a single specific number as a scientifically confirmed fact. This much can be accurately stated: reconstituted peptides are generally understood to degrade faster than their dry powder form, and refrigeration is consistently recommended over room-temperature storage once a peptide has been dissolved.
Does CJC-1295 require refrigeration?
In their unmixed, freeze-dried powder form, many peptides can tolerate limited periods at room temperature without significant degradation. However, freezing or refrigeration storage is still typically recommended by manufacturers and laboratory handling guides for maximising the long-term stability of dry powder, especially for extended storage measured in months. Once they have been mixed into a liquid solution, the guidelines change. Cooling becomes important, not optional. Dissolved peptides are more chemically active and more susceptible to degradation from room temperature, light exposure, and repeated handling.
Regarding the specific question about freezing reconstituted solution, general laboratory handling guidelines often advise against repeated freeze-thaw cycles. The physical process of freezing and thawing a liquid solution can potentially disrupt the peptide's structure. This occurs through the formation of ice crystals and mechanical stress on the molecule. Again, this is a broadly applicable principle in peptide handling, rather than a finding from a dedicated freeze-thaw study of CJC-1295.
Like the above stability numbers, these storage recommendations are consistent and sensible applications of general pharmaceutical science. They represent manufacturer guidelines and laboratory conventions, however, rather than independently published, peer-reviewed studies specific to this compound.
Limitations of current evidence
The storage and stability guidelines in this article are based on well-established general principles of peptide science. Dry, lyophilised peptides are more stable than dissolved ones. Refrigeration slows the degradation of reconstituted solutions. And repeated freeze-thaw cycling is generally discouraged. However, none of this comes from dedicated, independently published stability studies specifically for CJC-1295.
Commercial and laboratory sources commonly quote specific shelf-life windows, often somewhere between one to four weeks under refrigeration. However, these figures should be understood as manufacturer or vendor claims and general industry convention – not as validated findings from independent, peer-reviewed analytical research. No such research was identified in the scientific literature reviewed for this series.
Disclaimer
This content is for educational and informational purposes only and should not be interpreted as medical advice or validated storage instructions. CJC-1295 remains a research compound and is not approved by the FDA or European Medicines Agency for any medical use. The storage guidelines presented here reflect general, well-established principles for handling peptides rather than dedicated stability studies conducted specifically for this compound. Specific commercial shelf-life figures have not been independently verified by published studies.